Symptoms typically peak during treatment initiation and dose escalation, gradually diminishing over 812 weeks in most patients
While mild fatigue can be a manageable side effect, certain signs require immediate medical attention
Finally, it slows down gastric emptying, which is the process of food moving from the stomach into the small intestine
Two important points: 1) Context matters
Design and Baseline Characteristics of the FLOW Trial of Semaglutide in Patients With Type 2 Diabetes and Chronic Kidney Disease If this sounds like dj vu, that may be because Novo Nordisk previously implied that FLOW was positive on October 10 , 202 3 , when the trial was stopped early for efficacy (Figure 2)
Insurance coverage for anti-obesity medications varies [58], leading to inconsistent access across different populations